{"lastClose": 20.0, "len": 1175, "date": "2023-03-21", "alpha_1": 0.5823921893824522, "beta_1": 1.1968169374862572, "drawup_1": 1.1839339954257997, "sharpe_1": 0.6241960021649595, "natr_1": 6.435062580538872, "sup_1": -0.3903333028157553, "res_1": 0.004833348592122278, "bullPattern_1": ["ENGULFING", "SHORTLINE"], "bearPattern_1": [], "rsi_1": 29.927360041261537, "adx_1": 68.96846500568289, "drawdown_1": -0.3588862316705371, "stratHoldSharpe_1": 0.6581061736268712, "stratHoldAlpha_1": 251.38308080227034, "stratHoldDrawdown_1": -0.33848483170166643, "alpha_3mo": -0.7902851428537782, "beta_3mo": 1.1486254097361877, "drawup_3mo": 0.141231871863285, "natr_3mo": 6.435062580538872, "sup_3mo": -0.07749999364217111, "res_3mo": 0.10700000127156581, "bullPattern_3mo": [], "bearPattern_3mo": ["DARKCLOUDCOVER"], "rsi_3mo": 33.89121728478151, "adx_3mo": 52.71517182904979, "drawdown_3mo": -0.3588862316705371, "stratHoldSharpe_3mo": -2.1787204213518305, "stratHoldAlpha_3mo": 249.91094414245177, "stratHoldDrawdown_3mo": -0.3246605308621574, "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 1133099480, "Name": "Replimune Group Inc.", "IPO Year": 2018.0, "Sector": "Health Care", "Country": "United States", "alpha%_1": 0.9794023767920498, "beta%_1": 0.6740742884242925, "drawup%_1": 0.9637119963763634, "sharpe%_1": 0.5742215981482754, "natr%_1": 0.8173983378670739, "drawdown%_1": 0.5543981506502762, "stratHoldSharpe%_1": 0.8279286285906786, "stratHoldAlpha%_1": 0.9361002873381399, "stratHoldDrawdown%_1": 0.527304196828787, "alpha%_3mo": 0.08511935232585593, "beta%_3mo": 0.5865721858194658, "drawup%_3mo": 0.27311679909614706, "natr%_3mo": 0.8103817186597013, "drawdown%_3mo": 0.0563406286383764, "stratHoldSharpe%_3mo": 0.06344222041008349, "stratHoldAlpha%_3mo": 0.01949480753380617, "stratHoldDrawdown%_3mo": 0.06203581325972326}